Globus Medical, Inc. (GMED) Q1 2023 Earnings Call Transcript

Globus Medical, Inc. (NYSE:GMED) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET

Company Participants

Brian Kearns - Senior Vice President of Business Development and Investor Relations
Dan Scavilla - President and CEO
Keith Pfeil - Senior Vice President and Chief Financial Officer

Conference Call Participants

Mike Miksic - Barclays
Shagun Singh - RBC
David Saxon - Needham & Co
Sam Dane - BTIG
Kyle Rose - Canaccord
Vik Chopra - Wells Fargo

Operator

Welcome to Globus Medical’s First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I will now like to hand the conference over to your speaker today, Brian Kearns, Senior Vice President of Business Development and Investor Relations. Please go ahead.

Brian Kearns

Thank you, Antwone [ph] and thank you, everyone for being with us today. Joining today’s call from Globus Medical will be Dan Scavilla, President and Chief Executive Officer; and Keith Pfeil, Chief Financial Officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.

Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2021 fiscal year, and our subsequent filings with the Securities and Exchange Commission identifies certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K are available on our website.

We do not undertake to update any forward-looking statements as a result of new information or future events or developments. Our discussion today will also include certain financial